annual CFI:
$7.44M-$302.70M(-97.60%)Summary
- As of today (May 29, 2025), ASND annual cash flow from investing activities is $7.44 million, with the most recent change of -$302.70 million (-97.60%) on December 31, 2024.
- During the last 3 years, ASND annual CFI has risen by +$138.28 million (+105.69%).
- ASND annual CFI is now -97.60% below its all-time high of $310.14 million, reached on December 31, 2023.
Performance
ASND Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
N/ASummary
- ASND quarterly cash flow from investing activities is not available.
Performance
ASND quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM CFI:
N/ASummary
- ASND TTM cash flow from investing activities is not available.
Performance
ASND TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ASND Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -97.6% | - | - |
| 3 y3 years | +105.7% | - | - |
| 5 y5 years | +228.9% | - | - |
ASND Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -97.6% | +105.7% | ||||
| 5 y | 5-year | -97.6% | +102.2% | ||||
| alltime | all time | -97.6% | +102.2% |
ASND Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $7.44M(-97.6%) | -$542.40K(+44.9%) | $7.44M(-44.7%) |
| Sep 2024 | - | -$374.20K(-163.7%) | $13.46M(-64.2%) |
| Jun 2024 | - | $587.10K(-92.4%) | $37.60M(-59.0%) |
| Mar 2024 | - | $7.77M(+42.0%) | $91.67M(-70.4%) |
| Dec 2023 | $310.14M(+376.4%) | $5.47M(-77.0%) | $310.14M(+1.1%) |
| Sep 2023 | - | $23.77M(-56.5%) | $306.78M(+4.2%) |
| Jun 2023 | - | $54.66M(-75.8%) | $294.42M(+18.7%) |
| Mar 2023 | - | $226.24M(>+9900.0%) | $248.10M(+281.1%) |
| Dec 2022 | $65.10M(-149.8%) | $2.11M(-81.5%) | $65.10M(-193.8%) |
| Sep 2022 | - | $11.40M(+36.8%) | -$69.43M(+23.4%) |
| Jun 2022 | - | $8.34M(-80.7%) | -$56.25M(+9.7%) |
| Mar 2022 | - | $43.25M(-132.7%) | -$51.29M(-60.8%) |
| Dec 2021 | -$130.83M(-60.7%) | -$132.42M(-638.7%) | -$130.83M(+77.7%) |
| Sep 2021 | - | $24.58M(+84.9%) | -$73.63M(-14.7%) |
| Jun 2021 | - | $13.29M(-136.6%) | -$86.30M(-76.2%) |
| Mar 2021 | - | -$36.29M(-51.7%) | -$362.07M(+8.9%) |
| Dec 2020 | -$332.56M(+5658.1%) | -$75.21M(-731.7%) | -$332.56M(+28.6%) |
| Sep 2020 | - | $11.91M(-104.5%) | -$258.64M(-4.9%) |
| Jun 2020 | - | -$262.48M(+3773.1%) | -$271.91M(+2689.4%) |
| Mar 2020 | - | -$6.78M(+423.5%) | -$9.75M(+68.8%) |
| Dec 2019 | -$5.78M | -$1.29M(-4.7%) | -$5.78M(+0.2%) |
| Sep 2019 | - | -$1.36M(+326.5%) | -$5.76M(+0.6%) |
| Jun 2019 | - | -$318.40K(-88.6%) | -$5.73M(-1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$2.80M(+118.9%) | -$5.81M(+85.7%) |
| Dec 2018 | -$3.13M(+193.4%) | -$1.28M(-3.2%) | -$3.13M(+50.3%) |
| Sep 2018 | - | -$1.32M(+233.8%) | -$2.08M(+120.5%) |
| Jun 2018 | - | -$396.50K(+216.4%) | -$943.80K(+19.6%) |
| Mar 2018 | - | -$125.30K(-46.8%) | -$789.30K(-25.9%) |
| Dec 2017 | -$1.07M(+43.3%) | -$235.70K(+26.5%) | -$1.07M(+13.7%) |
| Sep 2017 | - | -$186.30K(-23.0%) | -$937.50K(+1.4%) |
| Jun 2017 | - | -$242.00K(-39.7%) | -$924.20K(-6.9%) |
| Mar 2017 | - | -$401.60K(+273.2%) | -$993.20K(+33.5%) |
| Dec 2016 | -$743.70K(-35.5%) | -$107.60K(-37.8%) | -$743.80K(-28.3%) |
| Sep 2016 | - | -$173.00K(-44.4%) | -$1.04M(+7.9%) |
| Jun 2016 | - | -$311.00K(+104.3%) | -$962.00K(-20.4%) |
| Mar 2016 | - | -$152.20K(-62.1%) | -$1.21M(+4.8%) |
| Dec 2015 | -$1.15M(+114.1%) | -$401.70K(+313.7%) | -$1.15M(+43.3%) |
| Sep 2015 | - | -$97.10K(-82.6%) | -$804.80K(+3.7%) |
| Jun 2015 | - | -$557.20K(+474.4%) | -$775.80K(+67.1%) |
| Mar 2015 | - | -$97.00K(+81.3%) | -$464.30K(-13.8%) |
| Dec 2014 | -$538.60K(-66.1%) | -$53.50K(-21.4%) | -$538.60K(+11.0%) |
| Sep 2014 | - | -$68.10K(-72.3%) | -$485.10K(+16.3%) |
| Jun 2014 | - | -$245.70K(+43.4%) | -$417.00K(+143.4%) |
| Mar 2014 | - | -$171.30K | -$171.30K |
| Dec 2013 | -$1.59M(+324.2%) | - | - |
| Dec 2012 | -$374.10K | - | - |
FAQ
- What is Ascendis Pharma A/S annual cash flow from investing activities?
- What is the all time high annual CFI for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual CFI year-on-year change?
- What is the all time high quarterly CFI for Ascendis Pharma A/S?
- What is the all time high TTM CFI for Ascendis Pharma A/S?
What is Ascendis Pharma A/S annual cash flow from investing activities?
The current annual CFI of ASND is $7.44M
What is the all time high annual CFI for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual cash flow from investing activities is $310.14M
What is Ascendis Pharma A/S annual CFI year-on-year change?
Over the past year, ASND annual cash flow from investing activities has changed by -$302.70M (-97.60%)
What is the all time high quarterly CFI for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly cash flow from investing activities is $226.24M
What is the all time high TTM CFI for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high TTM cash flow from investing activities is $310.14M